Exosomes: an opportunity for a new class of biologic therapies
Houman David Hemmati, MD PHD is the Vice President of Medical and Clinical Development for New Therapies at Capricor Therapeutics, Inc. in Beverly Hills, California. In this fascinating talk, he discussed the clinical trials at Capricor and the potential of these biotherapeutics in the pharmaceutical space. Capricor has three platforms: CDCs, Peptide therapy and microRNA exosomes: …